A Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del
Clinical trial NCT04105972 · COMPLETED
Trial details
- NCT number
- NCT04105972
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-03
- Primary completion
- 2020-07-24
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.